![David L. Guy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
David L.
Guy has been Chief Commercial Officer of Favrille, Inc. since December 2005.
Previously, he served as Vice President of Global Strategic Marketing and Business Development and Oncology for Schering AG/Berlex from 2002 to 2005 and as Director of Oncology Marketing for Genentech from 2000 to 2001.
Mr. Guy was US Business Unit Head of Oncology for Sanofi-Aventis from 1994 to 2000.
He received a BS degree in Biology and Molecular Genetics from McMaster University in Hamilton, Ontario.
Anciens postes connus de David L. Guy
| Sociétés | Poste | Fin |
|---|---|---|
Favrille, Inc.
 Favrille, Inc. Medical SpecialtiesHealth Technology Researches, develops and commercializes targeted immunotherapies for the treatment of cancer and diseases of the immune system | Corporate Officer/Principal | 22/04/2009 |
Bayer Schering Pharma AG
 Bayer Schering Pharma AG Medical SpecialtiesHealth Technology Manufactures pharmaceuticals and diagnostic substances | Corporate Officer/Principal | 01/01/2005 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Sales & Marketing | 01/01/2001 |
| SANOFI | Corporate Officer/Principal | 01/01/2000 |
Formation de David L. Guy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Bayer Schering Pharma AG
Bayer Schering Pharma AG Medical SpecialtiesHealth Technology Manufactures pharmaceuticals and diagnostic substances | Health Technology |
Favrille, Inc.
Favrille, Inc. Medical SpecialtiesHealth Technology Researches, develops and commercializes targeted immunotherapies for the treatment of cancer and diseases of the immune system | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
McMaster University
 McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
